{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T18:07:20Z","timestamp":1787594840861,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jiac.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T17:17:21Z","timestamp":1586539041000},"page":"706-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010\u20132018"],"prefix":"10.1016","volume":"26","author":[{"given":"Tomomi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Onozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2020.03.010_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","author":"GBD 2017 Cause of Death Collaborators","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2020.03.010_bib2","series-title":"The Institute for Health Metrics and Evaluation Japan: what causes the most deaths?","year":"2017"},{"key":"10.1016\/j.jiac.2020.03.010_bib3","series-title":"Demographic survey: cause of death. e-Stat. Japan statistics","year":"2017"},{"key":"10.1016\/j.jiac.2020.03.010_bib4","series-title":"The JRS guidelines for the management of pneumonia in adults","year":"2017"},{"issue":"Suppl 2","key":"10.1016\/j.jiac.2020.03.010_bib5","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of A and American Thoracic S. Infectious diseases society of America\/American thoracic society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2020.03.010_bib6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4212\/cjhp.v68i4.1472","article-title":"Addressing concerns about changing the route of antimicrobial administration from intravenous to oral in adult inpatients","volume":"68","author":"B\u00e9\u00efque","year":"2015","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.jiac.2020.03.010_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s10156-013-0618-5","article-title":"Early switch therapy from intravenous sulbactam\/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan","volume":"19","author":"Kohno","year":"2013","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2020.03.010_bib8","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jama.283.6.749","article-title":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia. Capital study investigators. Community-acquired pneumonia intervention trial assessing levofloxacin","volume":"283","author":"Marrie","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2020.03.010_bib9","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.38993.560984.BE","article-title":"Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial","volume":"333","author":"Oosterheert","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2020.03.010_bib10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0002-9343(01)00868-3","article-title":"Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial","volume":"111","author":"Castro-Guardiola","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.jiac.2020.03.010_bib11","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archinte.161.5.722","article-title":"Early switch and early discharge strategies in patients with community-acquired pneumonia: a meta-analysis","volume":"161","author":"Rhew","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2020.03.010_bib12","author":"Medical Data Vision"},{"key":"10.1016\/j.jiac.2020.03.010_bib13","author":"Japanese Society for Pharmacoepidemiology and Database Task Force"},{"key":"10.1016\/j.jiac.2020.03.010_bib14","series-title":"Act on the Protection of Personal Information","year":"2017"},{"key":"10.1016\/j.jiac.2020.03.010_bib15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2020.03.010_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijid.2019.04.020","article-title":"Efficacy and accuracy of qSOFA and SOFA scores as prognostic tools for community-acquired and healthcare-associated pneumonia","volume":"84","author":"Asai","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2020.03.010_bib17","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jiac.2020.03.010_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","article-title":"A\u00a0modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data","volume":"47","author":"van Walraven","year":"2009","journal-title":"Med Care"},{"key":"10.1016\/j.jiac.2020.03.010_bib19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"10.1016\/j.jiac.2020.03.010_bib20","first-page":"1","article-title":"Validation and recalibration of Charlson and Elixhauser Comorbidity Indices to predict in-hospital mortality in hospitalized patients in a Japanese hospital-based administrative database","volume":"25","author":"Kimura","year":"2020","journal-title":"Jpn J Pharmacoepidemiol"},{"key":"10.1016\/j.jiac.2020.03.010_bib21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1183\/09031936.00029412","article-title":"Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with cap","volume":"41","author":"Engel","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jiac.2020.03.010_bib22","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.2165\/0003495-200868170-00005","article-title":"Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis","volume":"68","author":"Athanassa","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.jiac.2020.03.010_bib23","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1001\/archinte.159.20.2449","article-title":"Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia","volume":"159","author":"Ramirez","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jiac.2020.03.010_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkp131","article-title":"Outcomes of early switching from intravenous to oral antibiotics on medical wards","volume":"64","author":"Mertz","year":"2009","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2020.03.010_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1062860604273748","article-title":"Getting physicians to make \u201cthe switch\u201d: the role of clinical guidelines in the management of community-acquired pneumonia","volume":"20","author":"Hagaman","year":"2005","journal-title":"Am J Med Qual"},{"key":"10.1016\/j.jiac.2020.03.010_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1525-1497.2003.20535.x","article-title":"Physician awareness and self-reported use of local and national guidelines for community-acquired pneumonia","volume":"18","author":"Switzer","year":"2003","journal-title":"J\u00a0Gen Intern Med"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20301008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X20301008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:00:14Z","timestamp":1761159614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X20301008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1341321X20301008"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2020.03.010","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Switching from intravenous to oral antibiotics in hospitalized patients with community-acquired pneumonia: A real-world analysis 2010\u20132018","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}